Do you want to read an article? Please log in or register.
AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease
Inflammatory Bowel Disease
Related content
RECOMMENDED
Inflammatory Bowel Disease
ACG Clinical Guideline: Management of Crohn's Disease in Adults
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Lichtenstein GR, Loftus EV, Afzali A, Long MD, Barnes EL, Isaacs KL, Ha CY
doi: 10.14309/ajg.0000000000003465
Esophagus Diseases
AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus
Gastroenterology
Wani S, Zhou MJ, Sawas T, Rubenstein JH, Eluri S, Leiman DA, Sultan S, Singh S, Inadomi J, Thrift AP, Katzka DA, Davitkov P
doi: 10.1053/j.gastro.2025.09.012
Inflammatory Bowel Disease
Efficacy and Safety of Risankizumab in Patients with Moderately to Severely Active Crohn's Disease: Interim Results from the SEQUENCE Open-Label Extension Study
J Crohns Colitis
Peyrin-Biroulet L, Atreya R, Danese S, Lindsay JO, Chapman JC, Anschutz T, Huang X, Zambrano J, van Haaren S, Joshi N, Duan WR, Cross RK
doi: 10.1093/ecco-jcc/jjaf213
Further Publications
AGA Clinical Practice Guideline on Management of Gastroparesis
Gastroenterology
Staller K, Parkman HP, Greer KB, Leiman DA, Zhou MJ, Singh S, Camilleri M, Altayar O, AGA Clinical Guidelines Committee
doi: 10.1053/j.gastro.2025.08.004
Inflammatory Bowel Disease
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension Study
J Crohns Colitis
Loftus EV Jr, D'Haens G, Louis E, Regueiro M, Jairath V, Magro F, Nakase H, Dubcenco E, Lacerda AP, Ford S, Feng T, Duncan B, Fish I, Cunneen C, Anyanwu SI, Aponte F, Griffith J, Blumenstein I
doi: 10.1093/ecco-jcc/jjaf138
Inflammatory Bowel Disease
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 GRAVITI Study
Gastroenterology
Hart A, Panaccione R, Steinwurz F, Danese S, Hisamatsu T, Cao Q, Ritter T, Seidler U, Olurinde M, Vetter ML, Yee J, Yang Z, Wang Y, Johanns J, Han C, Sahoo A, Terry NA, Sands BE, D'Haens G
doi: 10.1053/j.gastro.2025.02.033
Inflammatory Bowel Disease
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study
Am J Gastroenterol
Lee SD, Vermeire S, Ungaro R, Vadhariya A, Durand F, Morris N, Yu G, Fisher DA, Traxler K, Long M
doi: 10.14309/ajg.0000000000003410
Further Publications
Comparative Improvement in Health-Related Quality of Life with Advanced Therapies for Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis
Am J Gastroenterol
Olivera PA, Parks ML, Zubiaurre I, Peyrin-Biroulet L, Lasa JS, Targownik LE
doi: 10.14309/ajg.0000000000003333
Inflammatory Bowel Disease
Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges
Inflamm Bowel Dis
Jairath V, Adsul S, Allocca M, Danese S, Dubinsky MC, de Oliveira MF, Ma C, Kucharzik T, Novak KL, Panaccione R, Bautista IR, Sands BE, Taylor SA, Wilkens R, Maaser C
doi: 10.1093/ibd/izaf196